Dapiprazole

Dapiprazole
	File:Dapiprazole.svg
Clinical data
Pregnancy; category	US: B (No risk in non-human studies) ; ;
Routes of; administration	Topical (eye drops)
ATC code	S01EX02 (WHO) ;
Pharmacokinetic data
Bioavailability	Negligible when administered topically
Identifiers
	IUPAC name 3-{2-[4-(2-methylphenyl)piperazin-1-yl]ethyl}-5,6,7,8-; tetrahydro-[1,2,4]triazolo[4,5-a]pyridine;
CAS Number	72822-12-9;
PubChem CID	3033538;
DrugBank	APRD00902;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C19H27N5
Molar mass	325.451 g/mol
3D model (JSmol)	Interactive image;
	SMILES CC1=CC=CC=C1N2CCN(CC2)CCC3=NN=C4N3CCCC4;

Dapiprazole (U.S. trade name Rev-Eyes) is an alpha blocker. It is used to reverse mydriasis after eye examination.

Clinical data
File:Dapiprazole.svg
Pregnancy category	US: B (No risk in non-human studies)
Routes of administration	Topical (eye drops)
ATC code	S01EX02 (WHO)
Pharmacokinetic data
Bioavailability	Negligible when administered topically
Identifiers
IUPAC name 3-{2-[4-(2-methylphenyl)piperazin-1-yl]ethyl}-5,6,7,8- tetrahydro-[1,2,4]triazolo[4,5-a]pyridine
CAS Number	72822-12-9
PubChem CID	3033538
DrugBank	APRD00902
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₁₉H₂₇N₅
Molar mass	325.451 g/mol
3D model (JSmol)	Interactive image
SMILES CC1=CC=CC=C1N2CCN(CC2)CCC3=NN=C4N3CCCC4

Navigation menu